Stock Evaluator: NewGenIvf Group Limited (NIVF)

NewGenIvf Group Limited NIVF

$0.58 0.02 4.45%
August 21, 2026 4:00:00 PM EST November 10, 2021 Volume: 175,990
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Financial Summary

Share Statistics NIVF Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $3.5 $1,968.0 2%
Shares Out (Mil) 0.0 77.7 0%
Institutional Ownership 69.6% 86.6% 42%
Float (Mil) 5.9 52.1 14%
Beta -0.04 0.75 5%
Avg Daily Volume (000s) 1,045 612 71%
Price Change
(52-week)
(99.8%) 79.8% 1%
Growth NIVF Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 10.9% na
Net Income (5yr) na (1.6%) na
EPS (5yr) na 0.3% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (17.9%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials NIVF Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $5 $1,504 6%
Net Income (TTM) (Mil) $10 $28 46%
EPS (TTM) $644.197 $0.200 100%
Operating Cash Flow (TTM) (Mil) ($11) $162 19%
Net Cash Flow (TTM) (Mil) $0 $9 44%
Long-Term Debt (Q1) (Mil) $4 $338 24%
Enterprise Value (Q1) (Mil) $8 $2,416 7%
Valuation NIVF Industry
Median
Percentile
(All Stocks)
P/B na 2.82 na
P/E na 26.0 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios NIVF Industry
Median
Percentile
(All Stocks)
Gross Margin 20.2% 27.8% 21%
Net Margin 209.0% 1.2% 100%
ROA 54.4% 2.2% 99%
ROE 77.2% 7.2% 95%
Liabilities to Assets 20.6% 58.6% 14%
F-Score 3 5 na

Passing Stock Screens

As of 8/21/2026, from a list of 60 stock screening strategies, NIVF meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors